TP53 and cancer: In p53 mutation carriers, it was shown in three independent reports that individuals with the G-allele of SNP309 are diagnosed with cancer on average seven to fifteen years earlier than those p53 mutation carriers homozygous for the T-allele (Table 1) [6]-[8].